News

Under the agreement, the companies will work on process development and manufacturing for MorphoSys’ proprietary MOR208 program and other drug candidates. MOR208 is a monoclonal anti-CD19 antibody is

With this move, Novartis has joined Pfizer, GlaxoSmithKline and AstraZeneca, who have recently closed their R&D units in the UK. The Horsham site has almost 950 full-time equivalent

RGN-352 is an injectable formulation to treat cardiovascular and central nervous system diseases, as well as other medical indications. RegeneRx said that the suspension of the trial is

ACH-1625 is Achillion‘s phase 2 protease inhibitor to treat hepatitis C virus (HCV) infection. The new patent, entitled ‘4-amino-4-oxobutanoyl peptides as inhibitors of viral replication,’ provides a patent

PharmaPros claims that Dataflow Manager offers the ability to manage clinical trials using the most accurate and up-to-date information available, enabling trial managers to make rapid and better-informed

Pramlintide acetate is a synthetic analog of the natural hormone amylin, a neurohormone secreted by the pancreas that is known to play a role in the regulation of

The suit alleges Alnylam exploited its confidential relationship as a collaborator with Tekmira to engage in inappropriate and harmful conduct concerning Tekmira’s proprietary lipid nanoparticle (LNP) siRNA delivery

Tarceva is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) whose cancer has not spread or grown after initial treatment with certain types of chemotherapy (maintenance

The company said that with the completion of the certification process the providers will be able to use its EHR to successfully demonstrate meaningful use and qualify for